Abstract:1,3-Butanediol (1,3-BDO) is an important C4 platform chemical widely used as a solvent in cosmetics and a key intermediate for the synthesis of fragrances, pheromones, and pharmaceuticals. The development of sustainable bioprocesses to produce enantiopure 1,3-BDO from renewable bioresources by fermentation is a promising alternative to conventional chemical routes and has aroused great interest in recent years. Although two metabolic pathways have been previously established for the biosynthesis of (R)-1,3-PDO, the reported titer and yield are too low for cost-competitive production. In this study, we report the combination of different metabolic engineering strategies to improve the production of (R)-1,3-BDO by Escherichia coli, including (1) screening of key pathway enzymes; (2) increasing NADPH supply by cofactor engineering; (3) optimization of fermentation conditions to divert more flux into 1,3-BDO pathway; (4) reduction of byproducts formation by pathway engineering. With these efforts, the best engineered E. coli strain can efficiently produce (R)-1,3-BDO with a yield of 0.6 mol/mol glucose, corresponding to 60% of the theoretical yield. Besides, we also showed the feasibility of aerobically producing 1,3-BDO via a new pathway using 3-hydroxybutyrate as an intermediate.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssynbio.1c00144?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssynbio.1c00144</a>.List of primers used, screened enzymes, cofactor engineering to increase 1,3-BDO production under microaerobic condition, 1,3-BDO production by knocking out thioesterase genes, fed-batch fermentation of strain W3-34 (<a class="ext-link" href="/doi/suppl/10.1021/acssynbio.1c00144/suppl_file/sb1c00144_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Design, Evaluation, and Implementation of Synthetic Isopentyldiol Pathways in Escherichia coli

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Significantly Enhanced Production of Isoprene by Ordered Coexpression of Genes Dxs , Dxr , and Idi in Escherichia Coli

Engineering Escherichia coli via introduction of the isopentenol utilization pathway to effectively produce geranyllinalool

Metabolic Engineering of Escherichia coli for De Novo Production of 1,5-Pentanediol from Glucose

Efforts Toward Industrial Biosynthesis of Isoprene

The isoprenoid alcohol pathway, a synthetic route for isoprenoid biosynthesis

Metabolic Engineering and Regulation of Diol Biosynthesis from Renewable Biomass in Escherichia coli

New pathways and metabolic engineering strategies for microbial synthesis of diols.

Metabolic engineering and synthetic biology approaches driving isoprenoid production in Escherichia coli

Engineering Microbes for Isoprene Production

Production of C2–C4 diols from renewable bioresources: new metabolic pathways and metabolic engineering strategies

Metabolic Engineering of <i>Escherichia coli</i> for <i>De Novo</i> Production of 1,2-Butanediol

Expanding the isoprenoid building block repertoire with an IPP methyltransferase from Streptomyces monomycini.

Design an Energy‐Conserving Pathway for Efficient Biosynthesis of 1,5‐Pentanediol and 5‐Amino‐1‐Pentanol

Toward Biosynthetic Design and Implementation of Escherichia coli-Derived Paclitaxel and Other Heterologous Polyisoprene Compounds

Metabolic Engineering of Escherichia coli for High-Yield Production of ( R )-1,3-Butanediol

Clean synthesis of isoprene with six E. coli engineering strains

Efficient Production of 1,3-Propanediol from Diverse Carbohydrates via a Non-natural Pathway Using 3-Hydroxypropionic Acid as an Intermediate

Protein design and engineering of a de novo pathway for microbial production of 1,3-propanediol from glucose.

Efficient production of clerodane and ent-kaurane diterpenes through truncated artificial pathways in Escherichia coli